| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-06 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.2 | 6e-05 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-05 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.16 | 8e-05 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0002 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0002 |